Military Medical Research(IF:22.1) Protein & Cell(IF:22.1) National Science Review(IF:20.6) Science Bulletin(IF:18.9) Cancer Communications(IF:16.2) 看完以后,大家可能会觉着是国产期刊真的有问题,真的不要错怪好人了。科研猫查了一些和国产期刊相同影响因子的国际期刊,其实引用多来自“预警期刊”的情况是...
合作中心:浙江大学医学院附属妇产科医院 05 畸胎瘤来源卵巢鳞癌分子变异图谱 Ovarian squamous cell carcinoma associated with teratoma: a report of six cases with genomic analysi 癌种:卵巢鳞癌 杂志:Pathology 影响因子:4.5 合作中心:浙江大学医学院附属妇产科医院 结语 2023年的学术征程已圆满收官,世和基因感谢各位...
8、Cancer Communications 一区,2022-2023最新影响因子:16.2 9、 SEMINARS IN CANCER BIOLOGY 一区,2022-2023最新影响因子:14.5 10、Liver Cancer 一区,2022-2023最新影响因子:13.8 11、CANCER TREATMENT REVIEWS一区,2022-2023最新影响因子:11.8 12、CLINICAL CANCER RESEARCH 一区,2022-2023最新影响因子:11.5 13、J...
影响因子:20.1 年发文量:46 癌症通讯SCIE Cancer Communications ISSN:2523-3548 E-ISSN:2523-3548 是否OA:开放 出版地区:PEOPLES R CHINA 创刊时间:2018 是否预警:否 出版周期:Monthly 语言:English 研究方向:Biochemistry, Genetics and Molecular Biology - Cancer Research ...
该刊已被国际权威数据库SCIE收录,该刊致力于发表经过严格同行评审的高质量原创文章,反映Biochemistry, Genetics and Molecular Biology-Cancer Research领域的新进展、新技术、新成果,促进该领域科研交流和科研成果转化。该刊2023年影响因子为20.1,平均审稿速度为 4 Weeks ,近四年来没有被列入预警名单。如果您需要投稿发...
IF影响因子 20.1 是否预警 否 投稿咨询投稿指南 期刊简介 Journal Title:Cancer Communications Cancer Communications is an open access, peer-reviewed online journal that encompasses basic, clinical, and translational cancer research. The journal welcomes submissions concerning clinical trials, epidemiology, molecu...
中科新生命共收录到发表于2023年9月的客户文章46篇,其中包含Nature Metabolism,Nature Communications,Advanced Science,Nucleic Acids Research,The EMBO Journal,Redox Biology,Journal of Experimental & Clinical Cancer Research,EBioMedicine,Clinical and Translational Medicine等多篇10分以上的高分文章,平均影响因子高达...
影响因子(2023)3.889 Official Journal of the German Cancer Society (Deutsche Krebsgesellschaft). The "Journal of Cancer Research and Clinical Oncology" (formerly Zeitschrift für Krebsforschung, founded in 1904) contains significant and up-to-date articles within the fields of experimental, translational...
Cancer Communications(Chinese Journal of Cancer) is indexed in SCI and PubMed. The CJC publishes original research, reviews, perspectives, supplements, and spotlights in all areas of cancer research.